Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study
Our study added evidence of safety and tolerability of the adjuvanted recombinant RZV in frail adults.
Authors
- Walter Longanella
- Nadia Pecoraro (ORCID: https://orcid.org/0000-0002-1019-2769)
- Francesca Malatesta (ORCID: https://orcid.org/0009-0009-3073-4199)
- David Benvenuto
- Giuseppina Moccia (ORCID: https://orcid.org/0000-0002-7017-7413)
- Giovanni Genovese (ORCID: https://orcid.org/0000-0002-7636-958X)
- Valentina Giudice (ORCID: https://orcid.org/0000-0002-7492-6848)
- Francesco De (ORCID: https://orcid.org/0000-0001-9659-9940)
- Bianca Serio (ORCID: https://orcid.org/0000-0001-6613-2370)
- Maria Costantino (ORCID: https://orcid.org/0000-0002-1816-1609)
- Pio Sinopoli
- Simona Caruccio
- Giuliana Tremiterra
- Riccardo Rossiello
- Emilia Anna Vozzella
Institutions
- University of Salerno (IT)
- Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona (IT)
Publication Details
- Journal
- Vaccines
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3390/vaccines12090990
- Citations
- 6
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.32